Alzheimer's Disease meetings & conferences

Shank Regulation and Its Role in Disease

July 25-26, 2012 8:30 am - 5:30 pm Orlando, Florida

Scientific Symposium at the 2012 Phelan-McDermid Syndrome Int'l Family Conference & Scientific Symposium

Alzheimer's, schizophrenia, autism, and Phelan-McDermid Syndrome...what do these disorders have in common? What might disease-related findings tell us about the role of the Shank complex in disorders of the synapse? What are the molecular mechanisms, underlying these disorders of the synapse? Could potential therapeutic approaches have applications across all of these disorders of the synapse? Join us for what will surely be lively and thought-provoking sessions addressing these questions and more. The symposium will be a fertile field for innovation, cross-disease collaboration, and building of partnerships. We look forward to the participation of patient advocates, investigators, decision-makers and industry.

Contact Information: Vicki@pmsf.org
 

Mathematical and Computational Medicine Conference 2012

Saturday December 1 2012 - Wednesday December 5 2012 Xcaret, Mexico

The purpose of the Zing Conference on Mathematical and Computational Medicine is to bring together eminent scholars with expertise in various fields of mathematical and computational medicine, as well as experimentalists and medical doctors interested in application of computational methods in clinical studies. The mathematical and computational medicine is now one of the most important and rapidly growing fields of modern medicine, and will become even more important in nearest future, when the cost of individual human gene sequencing becomes affordable for mass-scale clinical use (The $1000 Human Genome). New sequencing techniques, such as RNA-Seq produce enormous amount of information on the transcriptome in healthy and diseased cells, that need a development of new mathematical and computational methods to extract the most important medical information. The scope of the proposed Zing Conference will cover many different fields mathematical and computational medicine and biomedical informatics, such as genetics, genomics, epigenetics, and epigenomics of various diseases including mental and learning disorders, autism, and somatic diseases, with a special emphasis on cancer, protein misfolding disorders related to amyloid formation in neurogenerative diseases (such as Alzheimer's and Parkinson's disease), gene regulation, biomarker development, computer aided drug development, computational pharmacodynamics, computational immunology, systems biology and its extension to systems medicine, machine learning methods in application to biomedical data, applicability of computational methods in personalized medicine, and regenerative medicine. A special session will be devoted to errors in measurements of biomedical data and statistical evidence-based medicine.

For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').

Neurodegeneration Conference 2012

Tuesday November 27 2012 - Saturday December 1 2012 Xcaret Mexico

This conference will focus on recent advances in neurodegenerative diseases, ranging from basic science to clinical and pharmaceutical developments, and will highlight current understanding of underlying mechanisms, new research directions, and therapeutic strategies. The conference will span Alzheimer's and other dementias twenty years since formulation of the amyloid cascade hypothesis, Parkinson's disease, prion diseases, as well as interactions and common mechanisms among neurodegenerative diseases. New concepts in any aspect of neurodegeneration/regeneration are, however, welcomed.

Featured will be plenary lectures from leading investigators, oral presentations from selected abstracts, and poster sessions covering each of the topics. Participation of younger scientists is particularly encouraged and there will be ample opportunity for informal discussions to develop new collaborations in an attractive environment on the Riviera Maya.

Contact us

For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').
 

Our Future is Aging: Current Research on Knowledge, Practice and Policy Research Conference

November 21st-23rd, 2012 Halifax, Nova Scotia, Canada

"Our Future is Aging: Current Research on Knowledge, Practice and Policy" research conference will be held on November 21-23, 2012, Delta Halifax Hotel, Halifax, Nova Scotia. This Conference will bring together researchers, academics, service providers, decision makers, artists, students, policy analysts and members of the community to share the diversity of perspectives and approaches to aging research within the Atlantic region and throughout Canada.

The Conference is being hosted by the Nova Scotia Centre on Aging, Mount Saint Vincent University as part of its 20th anniversary activities. Our Centre, in collaboration with a planning group of reseachers and representatives from practice and policy from throughout the region, are working to offer a valuable conference experience for you.

Atlantic Canada has the oldest populations in the country, and there is significant scholarly research on aging underway in the region that is not well known. This conference provides a unique opportunity for emerging and established researchers, practitioners, and policy makers in the region who are interested and engaged in age-related research to come together to learn about, and be inspired by, one another’s work. It offers an occasion to learn about existing collaborations in aging research, and foster new ones.

About the Organization

The NSCA is a research centre affiliated with the Department of Family Studies & Gerontology at Mount Saint Vincent University in Halifax, Nova Scotia, that was established in 1992. Through research, education and community engagement, the NSCA advances knowledge on aging to inform social policy and practice and enhance the quality of life of older people and their families. For more information on the NSCA visit www.msvu.ca/nsca.

2012 marks our 20th anniversary, and we are planning a special celebration. Our anniversary theme is Our Future is Aging. We chose this theme because it captures where we as a society are headed (our population is aging) and it reaffirms the work and mission of the NSCA to generate knowledge that informs policy and practice on aging related issues. Our Future is Aging: Current Research on Knowledge, Practice and Policy, is one event in the 20th Anniversary program of activities. This research conference supports two of the Centre’s strategic directions by fostering research collaborations and engaging in knowledge translation activities.

Travel Bursaries
If funding permits a limited number of travel bursaries may be available to students traveling to the conference. These bursaries will be distributed on a first-come-first serve basis, and will require the completion and submission of a student travel bursary form. Students are encouraged to identify their intent to apply for a travel bursary on the Online Submission form.

For additional information please consult the Nova Scotia Centre on Aging website: www.msvu.ca/nsca.

Halifax Nova Scotia B3M 2J6 Canada
Tel 902-457-6546 • Fax 902-457-6508

Email: nsca@msvu.ca
www.msvu.ca/nsca

Celebrating 20 Years of Advancing Aging Research and Enhancing Seniors' Lives

International Conference on Clinical Practice in Alzheimer Disease

Thursday, November 8, 2012 - Sunday, November 11, 2012 Budapest, Hungary

The International Conference on Clinical Practice in Alzheimer Disease (CPAD) aims to bring to families, patients researchers and clinicians the cutting-edge technologies, data and practical lure that are needed in clinical practice. The Conference will focus on the challenges of preventing, diagnosing and managing AD.

We hope to create with your help a meeting that will be interactive with each participant contributing his/her experience in a series of workshops, plenaries and presentations.

Clinical practice is not only our theme but the goal of this exciting new Conference.

Who Should Attend?

Psychiatrists
Neurologists
Researchers in the Alzheimer Field
Nurses
General Practitioners

Main Topics

MCI
Diagnosis
Rare Dementias
Treatment of Depression in Dementia
Treatment of Behavioral Problems in Dementia
National Strategies for Dementia

Clinical Practice in Alzheimer Disease – Conference Secretariat:
Paragon Conventions
Tel: +41 22 5330 948, Fax: +41 22 5802 953
Email: secretariat@cpadconference.com

Alzheimer's Association International Conference 2012

July 14-19, 2012 Vancouver, British Columbia, Canada

AAIC 2012 Topics of interest

Epidemiology and prevention
Genetics
Clinical diagnosis across the spectrum
Therapeutic strategies
Cellular and animal models
Molecular and cellular mechanisms of disease
Translational studies
Neuropsychological assessment
Social, behavioral and care research and practice
Related dementias
Systemic mechanisms of disease
Neuroimaging
And more

Alzheimer's Imaging Consortium (AIC) Topics of Interest
The AIC is a one day preconference on July 14, 2012. Submitted abstracts should focus on the clinical application and methodological development of neuroimaging (modalities including MRI, PET, SPECT, CT and others) to Alzheimer's disease, other dementias and normal brain aging.

National office
225 N. Michigan Ave., Fl. 17
Chicago, IL 60601-7633
tel: 312.335.8700
tdd: 312.335.5886
fax: 1.866.699.1246

e-mail: info@alz.org

11th International Conference on Alzheimer’s and Parkinson’s Diseases

March 6-10, 2013

AD/PD Florence will unite international medical professionals for a dynamic scientific program revealing cutting-edge research and discoveries in diagnosing, preventing and treating neurodegenerative diseases.

By serving as both an Alzheimer’s disease conference and a Parkinson’s disease conference, AD/PD 2013 delegates receive a greater variety of new data, a truly multi-disciplinary scientific agenda, and enhanced opportunities to network with leaders in the field of these distinct neurodegenerative diseases.